|
Re: In the near term we will continue our multi-point approach to progressing our corporate commercial value. This approach involves aggressive explorator
|
3
|
Resverlogix Corp.
|
Dec 06, 2019 09:25AM
|
|
Re: RESVERLOGIX ANNOUNCES PUBLICATION OF KEY APABETALONE STUDY BETONMACE IN THE JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
|
3
|
Resverlogix Corp.
|
Apr 01, 2020 11:57AM
|
|
Re: Received a response....Third Eye Loan Balance-Updated
|
3
|
Resverlogix Corp.
|
Jul 16, 2019 01:13PM
|
|
Exempt Distribution - November 16, 2022
|
3
|
Zenith Epigenetics
|
Dec 06, 2022 12:32PM
|
|
Re: Presentation is gone - Nose growing
|
3
|
Resverlogix Corp.
|
May 17, 2021 09:20AM
|
|
Re: What we know and what we don't.....
|
3
|
Resverlogix Corp.
|
May 16, 2019 03:55PM
|
|
Re: AGM
|
3
|
Resverlogix Corp.
|
Jun 20, 2023 10:03AM
|
|
Re: ACC 2019?
|
3
|
Resverlogix Corp.
|
Dec 07, 2018 10:50AM
|
|
Re: National Kidney Foundation -Abstract: BOM
|
3
|
Resverlogix Corp.
|
Mar 30, 2020 03:17PM
|
|
Re: Competition
|
3
|
Resverlogix Corp.
|
Nov 28, 2021 01:56PM
|
|
Re: NASDAQ here we come!!!
|
3
|
Resverlogix Corp.
|
Apr 23, 2019 04:34PM
|
|
Re: Still not finding on ClinicalTrials gov
|
3
|
Resverlogix Corp.
|
Apr 22, 2021 05:15AM
|
|
AGM 2024
|
3
|
Resverlogix Corp.
|
Apr 19, 2024 07:12AM
|
|
Re: Hmmm....
|
3
|
Resverlogix Corp.
|
May 02, 2019 10:47AM
|
|
Re: For what it’s worth
|
3
|
Zenith Epigenetics
|
Jul 19, 2023 10:40AM
|
|
Re: Tweet from Prof Kausik Ray
|
3
|
Resverlogix Corp.
|
Jun 02, 2020 08:05AM
|
|
Re: Short interest
|
3
|
Resverlogix Corp.
|
Apr 02, 2021 03:31PM
|
|
Additional Exempt Distribution- 2023-04-28
|
3
|
Zenith Epigenetics
|
May 09, 2023 09:33AM
|
|
Re: Question for posters
|
3
|
Resverlogix Corp.
|
Dec 10, 2021 07:12AM
|
|
Re: Interesting Trades / Volume .....
|
3
|
Resverlogix Corp.
|
Jan 27, 2019 05:57AM
|
